WO1997045547A2 - Mort cellulaire localisee dans des plantes - Google Patents

Mort cellulaire localisee dans des plantes Download PDF

Info

Publication number
WO1997045547A2
WO1997045547A2 PCT/EP1997/002749 EP9702749W WO9745547A2 WO 1997045547 A2 WO1997045547 A2 WO 1997045547A2 EP 9702749 W EP9702749 W EP 9702749W WO 9745547 A2 WO9745547 A2 WO 9745547A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
plants
plant
acid molecule
acid sequence
Prior art date
Application number
PCT/EP1997/002749
Other languages
German (de)
English (en)
Other versions
WO1997045547A3 (fr
Inventor
Lothar Willmitzer
Bernd Müller-Röber
Original Assignee
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. filed Critical MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.
Priority to AU31684/97A priority Critical patent/AU3168497A/en
Publication of WO1997045547A2 publication Critical patent/WO1997045547A2/fr
Publication of WO1997045547A3 publication Critical patent/WO1997045547A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
    • C12N15/8263—Ablation; Apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289—Male sterility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C12N9/1055—Levansucrase (2.4.1.10)

Definitions

  • the present invention relates to nucleic acid molecules which, when expressed in plants, lead to the production of localized cell death, and to plant cells and plants which contain such nucleic acid molecules.
  • Plants are attacked by various pathogens throughout.
  • a particular problem with regard to the attack of plants by pathogens arises in the current form of agriculture, which is characterized in that, due to the large-scale cultivation of monocultures, resistance introduced by means of breeding methods is overcome relatively quickly by mutations on the part of the pests.
  • the vertical resistance is generally a gene-for-gene relationship in the sense that a certain avirulence gene of the pathogen is opposed to a certain resistance gene of the plant. This means that vertical resistance is usually monogenic and therefore the easiest to break through.
  • the horizontal resistance is not inherited monogenously, but is usually determined by a series of loci. The horizontal resistance does not lead to complete resistance, as vertical resistance can, but is generally more permanent since many loci are involved.
  • HR hypersensitive reaction
  • the SAR represents an interesting special case of plant resistance to pathogens. It is characteristic here that a plant which has a SAR due to an infection by a specific pathogen does not only acquire the acquired resistance to the pathogen producing the SAR owns, but towards a much broader spectrum of pathogens.
  • the SAR is a very desirable reaction of the plant, since in many cases it results in a broad resistance that comes close to horizontal resistance (see, for example, Ryals et al. (1992) SEB Symposium 49, 205-229.
  • the mechanisms that lead to the formation of the SAR are partially understood.
  • SAR correlates with an increased level of salicylic acid (cf.
  • WO 95/31564 describes in a general way that the nucleotide sequence or sequences which are described in connection with localized cell death and the generation of SAR can comprise one or more genes, the specific exemplary embodiment being the resistance gene Cf-9 and the Avirulenzgen Ayr9 describes.
  • WO 95/31564 mentions the following possible approaches: an enzyme-conjugating enzyme, the gene VI protein from Cauliflower Mosaic Virus, a viral coat protein in simultaneous presence of a corresponding plant resistance gene, a bacterial hairpin protein, the N 'gene from tobacco, the potato virus coat protein and the avirulent dominant, as well as various resistance and avirulence gene combinations (e.g. Cf-2 from tomato and Ayr2 from C. fulvum, Cf-4 from tomato and Ayr4 from C. fulvum). Furthermore, an RNAse, the diphtheria toxin and proton pumps such as bacterial proton pumps are mentioned.
  • SAR is a very facultye resistance phenomenon.
  • the problem is that the SAR has not yet been able to be treated in breeding because presumably too many loci are involved and / or the gene products are unknown. It is therefore one of the tasks of bio-technological research to show alternative ways for both localized cell death and the SAR that is often associated with it.
  • the present invention is therefore based on the object of providing nucleic acid molecules with the aid of which localized cell death and optionally additionally systemically acquired resistance (SAR) can be triggered in plants or plant cells.
  • Another object of the invention is to provide nucleic acid molecules which can serve to produce male sterility in plants. Further objects of the invention will become apparent from the following description.
  • nucleic acid sequences can be used specifically to trigger localized cell death by triggering the generation of a protein or protein fragment, the enzymatic activity of which causes cell death.
  • a nucleic acid sequence from Erwinia amylovora which is a secreted form a Levansucrase coded, leads to the formation of HR in plants, which can also be coupled with the occurrence of SAR.
  • nucleic acid molecules which encode proteins or fragments thereof which, when expressed, lead to the death of the cell.
  • nucleic acid molecules according to the invention are nucleic acid molecules which encode proteins with the biological activity of a fructosyl transferase or a biologically active fragment thereof.
  • nucleic acid sequence is a nucleic acid sequence which encodes proteins with the biological activity of a levan sucrase or a biologically active fragment thereof, in particular a secreted levan sucrase.
  • biologically active fragment means that the mediated biological activity is sufficient to produce cell death.
  • Nucleic acid sequences which encode proteins with the enzymatic activity of a levan sucrase have been described from various organisms, e.g. from, Bacillus amyloliquefaciens (Tang et al. (1990) Gene 96, 89-93), Bacillus subtilis (Fönet et al. (1984) Biochem. Biophys. Res. Commun. 119, 795-800), Erwinia amylovora ( Geier and Geider (1993) Physiol. Mol. Plant Pathol. 42, 387-404; DE-Al 42 27 061).
  • a nucleic acid molecule according to the invention comprises the coding region from Erwinia amylovora mentioned in Example 1.
  • the present invention relates to nucleic acid molecules whose coding regions differ from sequences of the above-mentioned nucleic acid molecules due to the degeneration of the genetic code and which are a protein or encode a fragment thereof that has the biological activity of a levan sucrase, in particular a secreted levan sucrase.
  • nucleic acid sequence which encodes a protein with the biological activity of a levan sucrase or a biologically active fragment thereof can also be sequences which hybridize with one of the nucleic acid molecules described above.
  • biologically active fragments refers to fragments that can cause the plant cell to die.
  • hybridization means hybridization under conventional hybridization conditions, preferably under stringent conditions, as described, for example, in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. Nucleic acid sequences that hybridize with the above-mentioned molecules can e.g. can be isolated from genomic or from cDNA libraries.
  • nucleic acid sequences can be identified and isolated using the known nucleic acid molecules described above or parts of these molecules or the reverse complements of these molecules, e.g. by means of hybridization according to standard methods (see e.g. Sambrook et al., op. cit.).
  • nucleic acid molecules can be used as the hybridization probe that have exactly or essentially the nucleotide sequences listed above or parts of these sequences.
  • the used as a hybridization probe fragments may also be synthetic fragments spindles han ⁇ , HERGÉ by means of the conventional synthesizing methods and the sequence of which were ⁇ represents coincides with that of a known levansucrase-encoding Nucleinklaremole- CRWT substantially.
  • the molecules hybridizing with the known nucleic acid molecules also include fragments, derivatives and allelic variants of the DNA molecules described above, which encode a levan sucrase or a biological, i.e. enzymatically active fragment thereof. Fragments are understood to mean parts of the nucleic acid molecules that are long enough to encode a polypeptide with the enzymatic activity of a Levan sucrase or a comparable enzymatic activity that causes localized cell death.
  • the term derivative in this context means that the sequences of these molecules differ from the sequences of the above-described nucleic acid molecules at one or more positions and have a high degree of homology to these sequences.
  • Homology means a sequence identity of at least 40%, in particular an identity of at least 60%, preferably over 80% and particularly preferably over 90%.
  • the deviations from the nucleic acid molecules described above may have arisen through deletion, addition, substitution, insertion or recombination.
  • nucleic acid molecules which are homologous to the molecules described above and represent derivatives of these molecules are generally variations of these molecules which represent modifications which have the same biological function. This can involve both naturally occurring variations, for example sequences from other organisms, or mutations, it being possible for these modifications to have occurred naturally or to have been introduced by targeted mutagenesis. Furthermore, the variations can be synthetic. act sequences.
  • allelic variants can be both naturally occurring and synthetically produced variants or those produced by recombinant DNA techniques.
  • the proteins encoded by the different variants of the nucleic acid molecules have certain common characteristics. For this, e.g. Enzyme activity, molecular weight, immunological reactivity, conformation etc. belong. Other common characteristics can include physical properties such as e.g. represent the running behavior in gel electrophoresis, chromatographic behavior, sedimentation coefficients, solubility, spectroscopic properties, stability, optimum pH, optimum temperature, etc. Furthermore, the products of the reactions catalyzed by the proteins can of course have common or similar features.
  • the proteins encoded by the nucleic acid sequences have levan sucrase activity. The detection of the enzymatic activity of levan sucrase can be carried out, for example, by the detection of the formation of levan (cf.
  • the nucleic acid molecules according to the invention can be any nucleic acid molecules, in particular DNA or RNA molecules, for example cDNA, genomic DNA, mRNA etc. They can be naturally occurring molecules or those produced by genetic engineering or chemical synthesis methods.
  • nucleic acid molecules are present ⁇ the invention to regulatory elements linked to the ensure transcription and translation in the plant cell.
  • a particular advantage of the invention is that local cell death in plants can optionally be triggered in a targeted manner using the nucleic acid molecules according to the invention.
  • any promoter which is functional in the plants selected for the transformation and which fulfills the condition that the expression regulated by it leads to localized necrosis and that the plant does not become too large is suitable for the promoter mentioned Dying brings. Promoters which are specifically induced locally when infected by pathogens appear to be particularly useful for this purpose.
  • pathogen in the context of the present invention includes fungi, bacteria, viruses, insects and nematodes. Such promoters are known and described in the literature, cf. eg Martini et al.
  • RNA + RNA is isolated from a tissue infected with a specific pathogen and a cDNA library is created.
  • cDNA clones based on poly (A) + RNA molecules from a non-infected tissue are used to identify those clones from the first bank whose hybrid poly (A) + RNA is used -Molecules are only induced when the pathogen is infected.
  • Promoters are then isolated with the help of these cDNAs identified in this way, which can then be used for the expression of the coding nucleic acid sequences described here.
  • the nucleic acid sequence is in combination with the potato prpl-1 promoter.
  • nucleic acid sequence responsible for cell death with tissue-specific or development-specific promoters active in plants.
  • a nucleic acid molecule in which the coding nucleic acid sequence is under the control of an anther- or tapetum-specific promoter is particularly preferred.
  • Transposons are known to excite in somatic tissues. Such excisions result in the promoter and coding sequence being brought into direct contact and thus lead to the formation of the enzymatic activity responsible for the localized cell death. Transposons are described and cloned in the literature and are available in a wide range, e.g.
  • nucleic acid molecules according to the invention for generating a local cell death can in addition to the be ⁇ signed application to generate a systemic erwor ⁇ surrounded resistance (SAR) to pathogens and thus to He ⁇ generation of plants, the integrated resistance by an increased Krank ⁇ distinguished, even for the production of male sterile plants can be used.
  • Male sterile plants play an important role in plant breeding, especially in hybrid breeding.
  • the nucleic acid sequence coding for the enzymatic activity causing the cell death is coupled with an anther- or tape-specific promoter. Examples of such motors are mentioned, for example, in W092 / 13956 and W092 / 13957.
  • a restorer gene which can be used together with the nucleic acid sequence according to the invention, would suppress the enzymatic activity causing the cell death.
  • the region encoding a levan sucrase were used, the formation of the product, ie the levan, would be influenced by a simultaneous expression of a levanase in the cell space.
  • the expression of a corresponding antisense construct would influence the enzymatic activity causing the localized cell death due to antisense suppression.
  • the expression of the nucleic acid molecules according to the invention and thus the resulting cell-killing activity could be influenced by the phenomenon of cosuppression by the additional introduction of sense constructs into the plant cell.
  • nucleic acid sequences according to the invention can be used together with promoters which are induced in plants by abiotic stimuli, e.g. Chemicals, ozone, UV radiation, extreme temperatures, drought, salt can be induced.
  • promoters can be found in the literature, e.g. in Williams et al. (1992) Biotechnology 10, 540.
  • the enzymatic activity responsible for local cell death can be localized in any compartment of the plant cell.
  • the shape of the protein or a fragment thereof is selected which is localized in the extracellular space, ie in the apoplast.
  • the coding sequence of levansucrase is used, as has been isolated from Erwinia amylovora.
  • the nucleic acid molecule according to the invention contains a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript.
  • termination signals are known and can be interchanged with one another as desired.
  • An example of such a sequence is the termination signal of the octopine synthase gene from Agrobacterium tumefaciens.
  • nucleic acid sequences of the invention can be supplemented by enhancer sequences or other regulatory sequences.
  • regulatory sequences include e.g. also signal sequences that ensure that the gene product is transported to a specific compartment.
  • a nucleic acid molecule according to the invention preferably comprises a nucleotide sequence which codes an amino acid sequence which ensures the secretion of the protein.
  • the present invention further relates to vectors, in particular plasmids, cosmids, viruses, bacteriophages and other vectors common in genetic engineering, which contain the above-described nucleic acid molecules according to the invention and, if appropriate, for the transfer of the nucleic acid molecules according to the invention into plants or plant cells can be used.
  • vectors in particular plasmids, cosmids, viruses, bacteriophages and other vectors common in genetic engineering, which contain the above-described nucleic acid molecules according to the invention and, if appropriate, for the transfer of the nucleic acid molecules according to the invention into plants or plant cells can be used.
  • the invention also relates to host cells which are genetically modified with a nucleic acid molecule or vector according to the invention.
  • host cells which are genetically modified with a nucleic acid molecule or vector according to the invention.
  • These can be prokaryotic as well as eukaryotic cells.
  • it may be Mikroor ⁇ organisms, such as bacteria, viruses, fungi containing the OF INVENTION ⁇ to the invention nucleic acid sequences, that Mikroor- ganisms that are genetically modified with a nucleic acid molecule according to the invention.
  • it can also tie ⁇ generic cells.
  • nucleic acid molecules according to the invention there is now the possibility, using genetic engineering methods, to modify plant cells to the extent that they have a new enzymatic activity compared to wild-type cells and, as a result, to localize in plants which contain such cells Cell death can come.
  • the host cells according to the invention are plant cells which, owing to the presence and expression of an additionally introduced nucleic acid molecule according to the invention, have an enzymatic activity in comparison to non-transformed cells which is responsible for local cell death is.
  • these are transgenic plant cells which express a levan sucrase under the control of a pathogen-specific promoter.
  • the nucleic acid molecule according to the invention can be stably integrated into the genome of the plant cell.
  • the nucleic acid molecule encoding the enzymatic activity that causes cell death can be introduced into the cell as a self-replicating system.
  • the invention also relates to transgenic plants which contain the transgenic plant cells according to the invention described above, in which the nucleic acid molecules are integrated into the plant genome.
  • Plants are also the subject of the invention, in the cells of which a nucleic acid molecule according to the invention is present in self-replicating form, ie the plant cell contains the foreign DNA on an independent nucleic acid molecule.
  • the plants which are transformed with the nucleic acid molecules according to the invention and in which a protein responsible for localized cell death is synthesized due to the introduction of such a molecule can in principle be any plant. It is preferably a monocotyledon or dicotyledon crop.
  • Examples of monocot plants are the plants belonging to the genera Avena (oats), Triticum (wheat), Seeale (rye), Hordeum (barley), Oryza (rice), Panicum, Pennisetum, Setaria, Sorghum (millet), Zea (corn) belong.
  • Avena oats
  • Triticum wheat
  • Seeale rye
  • Hordeum barley
  • Oryza rice
  • Panicum Pennisetum
  • Setaria Sorghum
  • Sorghum mofetil
  • Zea corn
  • dicotyledonous crops cotton, legumes, such as legumes and in particular alfalfa, soybean, rapeseed, tomato, sugar beet, potato, ornamental plants, trees are to be mentioned among others.
  • Other useful plants can be fruit (in particular apples, pears, cherries, grapes, citrus, ananas and bananas), oil palms, tea, cocoa and coffee bushes, tobacco, sisal and, in the case of medicinal plants, rauwolfia and digitalis. Cereals, wheat, rye, oats, barley, rice, corn and millet, sugar beet, rapeseed, soy, tomato and potato are particularly preferred.
  • the invention furthermore relates to propagation material from plants according to the invention, for example seeds, fruits, cuttings, tubers, rhizomes etc., this propagation material containing transgenic plant cells described above.
  • the present invention also relates to parts of the plants according to the invention, such as e.g. Protoplasts, plant cells and calli that contain nucleic acid molecules according to the invention.
  • the invention also relates to plants which, owing to the expression of the nucleic acid molecules according to the invention, have an increased salicylic acid concentration in comparison to plants which do not contain the nucleic acid molecules.
  • the invention further relates to plants which, in comparison to plants, contain the nucleic acid molecules according to the invention not included, characterized by increased disease resistance.
  • these are plants which, owing to the expression of a levan sucrase gene from E. amylovora, show local cell death which may be associated with the expression of a SAR.
  • the present invention also relates to plants which are male-sterile due to the expression of a nucleic acid molecule according to the invention.
  • the present invention relates to a method by means of which it is possible to produce plants which show a localized cell death and which may additionally be characterized by the acquisition of an SAR, and plants which are male-sterile due to the localized cell death .
  • plants or plant cells can be modified with the aid of conventional genetic engineering transformation methods such that a nucleic acid molecule according to the invention is integrated into the plant genome, i.e. that stable transformants are generated.
  • a nucleic acid molecule according to the invention the expression of which in the plant cell causes the cell to die, can be contained in the plant cell or the plant as a self-replicating system.
  • the nucleic acid molecules according to the invention can e.g. be contained in a virus with which the plant or plant cell comes into contact.
  • plant cells which have an activity causing cell death due to the expression of a nucleic acid molecule according to the invention are produced by a process which comprises the following steps: (a) Production of an expression cassette which comprises the following sequences:
  • nucleic acid sequence which encodes a protein or a fragment thereof, the enzymatic activity of which causes localized cell death in plants, the nucleic acid sequence being coupled in sense orientation to the 3 'end of the promoter;
  • nucleic acid molecules according to the invention can as a self-replicating system in ⁇ These crops zenzelle or plant are introduced.
  • the invention is also the use of a pathogen-specific promoter, in particular the prpl-1 promoter for the production of plants in which a cell death occurs thanksi ⁇ lized and / or the at least one typical for a systemic acquired resistance trait and / or increased Have disease resistance compared to wild ⁇ type plants.
  • a pathogen-specific promoter in particular the prpl-1 promoter for the production of plants in which a cell death occurs thanksi ⁇ lized and / or the at least one typical for a systemic acquired resistance trait and / or increased Have disease resistance compared to wild ⁇ type plants.
  • the invention also relates to the use of nucleic acid sequences ⁇ that tivity a protein having the enzymatic Akti ⁇ a levansucrase encode for generating of plant zen, which are characterized by a localized cell death, as well as for the production of a localized cell death in plants. Also, the present invention relates to the Verwen ⁇ dung such nucleic acid to produce a systemic acquired resistance in plants, to increase the salicylic acid concentration in plants and / or He ⁇ disease resistance heightening in plants.
  • the invention further relates to the use of a protein with the enzymatic activity of a levan sucrase in order to cause localized cell death in plants.
  • the present invention also relates to the use of nucleic acid sequences which encode proteins with the biological activity of a levan sucrase, or such proteins, for producing male sterility in plants.
  • the present invention thus encompasses every possible form of use of the nucleic acid molecules according to the invention, the expression of which in plants causes the death of cells, and of the proteins or fragments thereof according to the invention, the enzymatic activity of which causes cell death.
  • cloning vectors which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells.
  • examples of such vectors are pBR322, pUC series, M13mp series, paCYC184 etc.
  • the desired sequence can be introduced into the vector at a suitable restriction interface.
  • the plasmid obtained is used for the transformation of E. coli cells.
  • Transformed E. coli cells are grown in a suitable medium and then harvested and lysed.
  • the plasmid is recovered.
  • analysis method for characterizing the plasmid DNA obtained generally restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are used. After each manipulation, the plasmid DNA can be cleaved and the DNA fragments obtained can be linked to other DNA sequences.
  • Each plasmid DNA sequence can be cloned into the same or other plasmids.
  • a large number of known techniques are available for introducing DNA into a plant host cell, and the person skilled in the art can determine the appropriate method in each case without difficulty. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, the fusion of protoplasts, the direct gene transfer of isolated DNA into protoplasts, the electroporation of DNA, the introduction of DNA by means of the biolistic method and other possibilities.
  • the nucleic acid molecules according to the invention for example can be introduced into the cells via a viral infection as a self-replicating system without subsequent integration into the plant genome.
  • the Ti or Ri plasmid is used for transformation of the plant cell, it should be at least the right border, but often the right and left Be ⁇ limitation of the T-DNA contained in the Ti- and Ri-plasmid as Flanking region to the genes to be introduced linked to ⁇ .
  • the DNA to be introduced should be cloned into special plasmids, either in an intermediate or in a binary vector.
  • the intermediate vectors can on ⁇ Due to sequences that are homologous to sequences in the T-DNA by homologous recombination into the Ti or Ri-Plas ⁇ the Agrobacteria mid be integrated. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria.
  • the intermediate vector can be transferred to Agrobacterium tumefaciens by means of a helper plasmid
  • Binary vectors can replicate in E. coli as well as in Agrobacteria. They contain a selection marker gene and a linker or polylinker, which are framed by the right and left T-DNA border region. They can be transformed directly into the agrobacteria
  • the Agrobacterium serving as the host cell should contain a plasmid which carries a vir region.
  • the vir region is usually necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present.
  • the agrobacterium transformed in this way is used for the transformation of plant cells.
  • T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 120 515; Hoekema in: The Binary Plant Vector System, Offsetdrokkerij Kanters BV, Alblasserdam (1985) Chapter V; Fraley et al. (1993) Crit. Rev. Plant. Be. 4, 1-46 and An et al. (1985) EMBO J. 4, 277-287.
  • plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes. From the infected plant material (e.g.
  • leaf pieces, stem Segments, roots, but also protoplasts or suspension-cultivated plant cells can then regenerate whole plants again in a suitable medium, which can contain antibiotics or biocides for the selection of transformed cells.
  • the plants are regenerated by customary regeneration methods using known nutrient media.
  • the plants thus obtained can then be examined for the presence of the introduced DNA.
  • Other possibilities of introducing foreign DNA using the biolostic method or by means of protoplast transformation are known (cf., for example, Willmitzer L. (1993) Transgenic Plants, in: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ Rehm, G. Reed , A. Pühler, P. Stadler, eds., Vol. 2, 627-659, VCH Weinheim - New York - Basel - Cambridge).
  • Zen Alternative systems for Tansformation of monocotyledonous Pflan ⁇ are the transformation by means of the biolistic An ⁇ set (Wan and Lemaux (1994) Plant Physiol 104, 37-48;. Vasil et al (1993) Bio / Technology 11, 1553-1558.; Ritala et al. (1994) Plant Mol. Biol. 24, 317-325; Spencer et al. (1990) Theor. Appl. Genet. 79, 625-631), the protoplast transformation, the electroporation of partially permeabilized Cells, the introduction of DNA using glass fibers.
  • EP 292 435 describes a process by means of which fertile plants can be obtained starting from a slimy, soft (friable) granular corn callus. Shillito et al.
  • the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains a selection marker which imparts resistance to the transformed plant cells to a biocide or an antibiotic such as kanamycin, G418, bleomycin, hygromycin, methotrexate, glyphosate, streptomycin, sulfonylurea, gentamycin or phosphinotricin and others.
  • the individually selected marker should therefore allow the selection of transformed cells over cells that lack the inserted DNA.
  • the transformed cells grow within the plant in the usual way (see also McCormick et al. (1986) Plant Cell Reports 5, 81-84).
  • the resulting plants can be grown normally and crossed with plants that have the same transformed genetic makeup or other genetic makeup.
  • the resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plants.
  • transgenic lines can be determined by conventional methods, which are homozygous for the new nucleic acid molecules and which investigate and investigate their phenotypic behavior with regard to localized cell death and / or SAR and / or increased disease resistance and / or male sterility with that of hemizygote lines.
  • Figure 1 shows the appearance of necrotic areas in transgenic tobacco plants with the construct
  • Figure 2 shows the amount of salicylic acid in transgenic tobacco plants (1-5) compared to wild-type plants (6-7).
  • Figure 3 shows the result of a Northern blot experiment. 30 ⁇ g poly (A) + mRNA from different transgenic tobacco plants (lane 1-5) and two non-transformed tobacco plants (lane 6-7) were used for the analysis. A cDNA of the PR-1 l gene was used as a probe. 23
  • the vector pBluescript II SK (Stratagene) was used for cloning in E. coli.
  • E. coli strain DH5alpha (Bethesda Research Laboratories, Gaithersburgh, USA) was used for the Bluescript vector and the Lss8 constructs.
  • the leaves were then used for callus induction on MS medium with 1.6% glucose, 5 mg / 1 naphthylacetic acid, 0.2 mg / 1 benzylaminopurine, 250 mg / 1 claforan, 50 mg / 1 kanamycin and 0.8 % Bacto agar placed. After incubation for one week at 25 ° C. and 3000 lux, the leaves were induction on MS medium with 1.6% glucose, 1.4 mg / 1 zeatin ribose, 20 ⁇ g / 1 naphthylacetic acid, 20 ⁇ g / 1 giberellic acid, 250 mg / 1 Claforan, 50 mg / 1 kanamycin and 0.8% Bacto agar.
  • RNA extraction and Northern blot experiments RNA was isolated from frozen plant material, as described in Logemann et al. (1987) Anal. Biochem. 163, 21-26. The RNA was denatured in 40% formamide. The .RNA was then separated by gel electrophoresis on formaldehyde / agarose gels and blotted on nylon membranes (Hybond N; Amersham, UK) after the gel run. Hybridization against a radioactively labeled DNA probe was carried out according to standard methods (e.g. Sambrook et al, op. Cit.).
  • Potato plants (Solanum tuberosum) were kept in the greenhouse ⁇ house at 60% humidity and 22 ° C for 16 hours in the light and 15 ° C for 8 hours in darkness.
  • Tobacco plants (Nicotiana tabacum) were kept in the greenhouse at 60% humidity and 25 ° C for 14 hours in the light and 20 ° C for 10 hours in the dark. 7. Determination of salicylic acid contents:
  • the resulting binary vector thus contains the prpl-1 promoter region and the termination signal of the octopine synthase gene (OCS) separated by restriction sites of the pUC18 polylinker, which allows the insertion of coding regions and thus the construction of appropriate expression cassettes.
  • OCS octopine synthase gene
  • Transgenic tobacco and potato plants were transformed, selected and regenerated as described above. After rooting in stone culture, approx. 50 independent transformants were transferred to soil in the greenhouse. 6 to 8 lines which had a phenotype clearly identified by the appearance of necrotic spots could be identified (see FIG. 1). The analysis of these necrotic areas for the presence of Levan by the method described above clearly provided evidence of Levan. These plants, which had localized cell death due to the expression of the chimeric gene construct pLSS8, were then subjected to further analyzes in the greenhouse.
  • the salicylic acid content of various transformants was determined using the methods given above. As can be seen from Figure 2, the transgenic tobacco plants, which are characterized by localized cell death, have a 2-8 times higher amount of salicylic acid compared to wild-type plants.
  • SAR Systemic acquired resistance
  • PR proteins pathogenesis-related proteins
  • PR proteins pathogenesis-related proteins
  • FIG. 3 The expression of PR proteins in plants which express the chimeric Lss8 gene was examined by means of Northern blot analysis. As can be seen in FIG. 3, the expression of the homologous PRI-1 gene can be detected both in green and in areas of the tobacco plants which already have necrotic spots, while in non-transformed areas Control plants are not.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des molécules d'acide nucléique servant à produire une mort cellulaire localisée dans des plantes, ainsi que des vecteurs contenant de telles molécules d'acide nucléique, et des cellules végétales et des plantes modifiées génétiquement avec de telles molécules d'acide nucléique.
PCT/EP1997/002749 1996-05-29 1997-05-27 Mort cellulaire localisee dans des plantes WO1997045547A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31684/97A AU3168497A (en) 1996-05-29 1997-05-27 Localised cell death in plants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19621572.2 1996-05-29
DE1996121572 DE19621572A1 (de) 1996-05-29 1996-05-29 Lokalisierter Zelltod in Pflanzen

Publications (2)

Publication Number Publication Date
WO1997045547A2 true WO1997045547A2 (fr) 1997-12-04
WO1997045547A3 WO1997045547A3 (fr) 1998-01-15

Family

ID=7795604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/002749 WO1997045547A2 (fr) 1996-05-29 1997-05-27 Mort cellulaire localisee dans des plantes

Country Status (3)

Country Link
AU (1) AU3168497A (fr)
DE (1) DE19621572A1 (fr)
WO (1) WO1997045547A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043821A1 (fr) * 1998-02-26 1999-09-02 Pioneer Hi-Bred International, Inc. Genes activant le systeme de defense de plantes contre les elements pathogenes
EP0957672A1 (fr) * 1996-12-05 1999-11-24 Cornell Research Foundation, Inc. Traitement de graines conferant a des plantes une resistance induite par une reaction d'hypersensibilite
WO2000015817A2 (fr) * 1998-09-17 2000-03-23 Pioneer Hi-Bred International, Inc. Genes de type stomatine et utilisation de ces genes dans des plantes

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271439B1 (en) 1998-03-04 2001-08-07 Pioneer Hi-Bred International, Inc. Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255378A2 (fr) * 1986-07-31 1988-02-03 Calgene, Inc. Régulation de transcription spécifique pour des graines
EP0392225A2 (fr) * 1989-03-24 1990-10-17 Ciba-Geigy Ag Plantes transgéniques résistantes aux maladies
DE4227061A1 (de) * 1992-08-12 1994-02-17 Inst Genbiologische Forschung DNA-Sequenzen, die in der Pflanze die Bildung von Polyfructanen (Lävanen) hervorrufen, Plasmide enthaltend diese Sequenzen sowie Verfahren zur Herstellung transgener Pflanzen
WO1995031564A2 (fr) * 1994-05-11 1995-11-23 John Innes Centre Innovations Limited Procede d'introduction d'une resistance aux agents pathogenes chez les vegetaux

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856241T2 (de) * 1987-05-20 1999-03-25 Novartis Ag, Basel Verfahren zur Herstellug von transgene Zea mays-Pflanzen, die aus Protoplasten oder aus von Protopflasten erhaltenen Zellen regeneriert wurden
US7705215B1 (en) * 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
NL9000773A (nl) * 1990-04-02 1991-11-01 Rijkslandbouwhogeschool Werkwijze voor het beschermen van planten tegen pathogenen.
ATE223148T1 (de) * 1990-06-23 2002-09-15 Aventis Cropscience Gmbh Verbesserte genotypen von zea mays (l.) mit der veranlagung zur langfristigen, höchst effizienten pflanzenregeneration
ATE381622T1 (de) * 1991-02-07 2008-01-15 Bayer Bioscience Nv Staubblatt spezifische promotoren aus mais
JP3462497B2 (ja) * 1991-02-08 2003-11-05 バイエル・バイオサイエンス・エヌ・ヴェー コメ由来の雄ずい特異的プロモーター
DE4417879A1 (de) * 1994-05-18 1995-11-23 Inst Genbiologische Forschung DNA-Sequenzen die die Synthese linearer alpha-1,4-Glukane in Pflanzen, Pilzen und Mikroorganismen ermöglichen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255378A2 (fr) * 1986-07-31 1988-02-03 Calgene, Inc. Régulation de transcription spécifique pour des graines
EP0392225A2 (fr) * 1989-03-24 1990-10-17 Ciba-Geigy Ag Plantes transgéniques résistantes aux maladies
DE4227061A1 (de) * 1992-08-12 1994-02-17 Inst Genbiologische Forschung DNA-Sequenzen, die in der Pflanze die Bildung von Polyfructanen (Lävanen) hervorrufen, Plasmide enthaltend diese Sequenzen sowie Verfahren zur Herstellung transgener Pflanzen
WO1995031564A2 (fr) * 1994-05-11 1995-11-23 John Innes Centre Innovations Limited Procede d'introduction d'une resistance aux agents pathogenes chez les vegetaux

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
G. GEIER AND K. GEIDER: "Characterization and influence on virulence of the levansucrase gene from the fireblight pathogen Erwinia amylovora" PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY, Bd. 42, 1993, LONDON, GB, Seiten 387-404, XP002044933 in der Anmeldung erw{hnt *
N. MARTINI ET AL.,: "Promoter sequences of a potato pathogenesis-related gene mediate transcriptional activation selectively upon fungal infection" MOLECULAR & GENERAL GENETICS, Bd. 236, 1993, BERLIN, DE, Seiten 179-186, XP002044934 in der Anmeldung erw{hnt *
R. HOFGEN AND L. WILLMITZER: "Transgenic potato plants depleted for the major tuber protein patatin via expression of antisense RNA" PLANT SCIENCE, Bd. 87, 1992, AMSTERDAM, NL, Seiten 45-54, XP002044935 in der Anmeldung erw{hnt *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957672A1 (fr) * 1996-12-05 1999-11-24 Cornell Research Foundation, Inc. Traitement de graines conferant a des plantes une resistance induite par une reaction d'hypersensibilite
EP0957672A4 (fr) * 1996-12-05 2005-01-26 Cornell Res Foundation Inc Traitement de graines conferant a des plantes une resistance induite par une reaction d'hypersensibilite
WO1999043821A1 (fr) * 1998-02-26 1999-09-02 Pioneer Hi-Bred International, Inc. Genes activant le systeme de defense de plantes contre les elements pathogenes
WO2000015817A2 (fr) * 1998-09-17 2000-03-23 Pioneer Hi-Bred International, Inc. Genes de type stomatine et utilisation de ces genes dans des plantes
WO2000015817A3 (fr) * 1998-09-17 2000-06-08 Pioneer Hi Bred Int Genes de type stomatine et utilisation de ces genes dans des plantes

Also Published As

Publication number Publication date
WO1997045547A3 (fr) 1998-01-15
AU3168497A (en) 1998-01-05
DE19621572A1 (de) 1997-12-04

Similar Documents

Publication Publication Date Title
DE69929073T2 (de) Verfahren und Zusammensetzungen für die Transformation von Pflanzen
DE60017781T2 (de) Modulation der antwort einer pflanze auf abscisin säure
DE69933713T2 (de) Mais alpha-tubulin 3-18 Promoter
DE69535563T2 (de) Transgene pflanzen, die dna-konstrukte expremieren, die mehrere virusresistenz-verleihende gene enthalten
DE602004004070T2 (de) Verwendung der regulatorischen sequenz des gos2-gens aus reis für die genexpression in dikotyledonen pflanzen oder pflanzenzellen
DE69928264T2 (de) Samen-bevorzugende promotoren
DE4004800C2 (de) Im Habitus und Ertrag veränderte transgene Pflanzen
DE60216116T2 (de) Für Gefässgewebe spezifische Promotoren
EP0375091A1 (fr) Régulation de transcription inductible par blessure spécifique pour des tubercules de pommes de terre
JPH07506485A (ja) 真菌応答性キメラ遺伝子
EP0462065B1 (fr) Nouvelles séquences de signal
DE69731655T2 (de) Gegen pilze gerichtete proteine, dafuer kodierende dna und wirtsorganismen, die diese beinhalten
EP0418695A1 (fr) Séquence d'ADN régulatoire
DE60035892T2 (de) Gene und verfahren zur wachstumsmanipulation
DE69633568T2 (de) Expressionskontrollesequenz zur allgemeinen und effektiven genexpression in pflanzen
DE69433238T2 (de) Pflanzenpromoter, microorganismen und pflanzenzellen mit einer expressionseinheit für ein gewünschtes protein, das besagten promoter enthält
DE69332148T2 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
DE60131075T2 (de) Durch freisetzung in geschlossener, zirkulärer form aus einer grösseren nukleotidsequenz charakterisiertes konstrukt, welches die ortsspezifische und/oder entwicklungsspezifische, regulierte expression selektierter, genetischer sequenzen erlaubt
EP2487245A2 (fr) Procédé d'augmentation de la résistance aux pathogènes de plantes transgéniques
DE3751099T2 (de) Gegen Viren resistente Pflanzen mit einem viralen Überzugsprotein.
WO1997045547A2 (fr) Mort cellulaire localisee dans des plantes
WO1996013595A1 (fr) Procede permettant de modifier la floraison de plantes
EP0492536A2 (fr) Méthode de production de plantes résistantes aux pathogènes
EP0428881A1 (fr) ARNs à activité endonucléase et antisens, leurs production et utilisation
WO2006097465A2 (fr) Procede permettant d'augmenter la resistance aux champignons de plantes transgeniques par suppression, induite par un hote, de l'expression genique des champignons pathogenes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN IL JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA CN IL JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: JP

Ref document number: 97541606

Format of ref document f/p: F

NENP Non-entry into the national phase in:

Ref country code: CA

122 Ep: pct application non-entry in european phase